The EORTC CLTF 20-21 Meeting took place from 14-16 October, 2021, as both a live meeting in Marseille, France, and as a virtual event. This meeting covered the latest updates in cutaneous lymphoma.

Related content: Managing CD30+ CTCL: UK patient experience

Managing CD30+ CTCL - UK Patient Experience
View all videos

EORTC CLTF 2021

The European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 20-21 Meeting
14–16 October 2021 | Hybrid: Marseille, France & Virtual

Muhammad Umair Mushtaq (@KUMedCenter) discusses outcomes of alloHSCT in TP53-mutated AML and MDS:

👉http://ow.ly/I7PX50J8F9s👈

@ASTCT @CIBMTR #Tandem22 #MDSsm #LeuSM #AMLsm #Leukemia #MyelodysplasticSyndromes #HemOnc #BMTsm

2 weeks to go until #ASCO22! 🎉

We’re counting down to one of the biggest oncology congresses of the year – stay tuned with VJHemOnc for the highlights in hematological cancers! 👩‍⚕️👨‍⚕️

@ASCO

Pieter Sonneveld (@ErasmusMC) shares some insights on how to approach myeloma patients with high-risk cytogenetics at #COMy22.

Watch now:

🎥: http://ow.ly/LKlF50J8EW3

@COMyCongress #MMsm #HemOnc #Myeloma

Day 3 highlights from #COMy22 - we had such a lovely time!

Our expert-led interviews are now live on:

👉http://ow.ly/NxEa50JayAm👈

@COMyCongress @Mohty_EBMT @SagarLonialMD #MMsm #Myeloma #HemOnc

We're pleased to bring you our latest podcast! Join leading experts as they discuss the impact of artificial intelligence and machine learning in the treatment of MDS:

🎧: http://ow.ly/1Akr50J8EBm

#MDSsm #MyelodysplasticSyndromes

Load More...

EORTC CLTF 2021

The European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 20-21 Meeting
14–16 October 2021 | Hybrid: Marseille, France & Virtual

The EORTC CLTF 20-21 Meeting took place from 14-16 October, 2021, as both a live meeting in Marseille, France, and as a virtual event. This meeting covered the latest updates in cutaneous lymphoma.

Related content: Managing CD30+ CTCL: UK patient experience

Managing CD30+ CTCL - UK Patient Experience
View all videos

Muhammad Umair Mushtaq (@KUMedCenter) discusses outcomes of alloHSCT in TP53-mutated AML and MDS:

👉http://ow.ly/I7PX50J8F9s👈

@ASTCT @CIBMTR #Tandem22 #MDSsm #LeuSM #AMLsm #Leukemia #MyelodysplasticSyndromes #HemOnc #BMTsm

2 weeks to go until #ASCO22! 🎉

We’re counting down to one of the biggest oncology congresses of the year – stay tuned with VJHemOnc for the highlights in hematological cancers! 👩‍⚕️👨‍⚕️

@ASCO

Pieter Sonneveld (@ErasmusMC) shares some insights on how to approach myeloma patients with high-risk cytogenetics at #COMy22.

Watch now:

🎥: http://ow.ly/LKlF50J8EW3

@COMyCongress #MMsm #HemOnc #Myeloma

Day 3 highlights from #COMy22 - we had such a lovely time!

Our expert-led interviews are now live on:

👉http://ow.ly/NxEa50JayAm👈

@COMyCongress @Mohty_EBMT @SagarLonialMD #MMsm #Myeloma #HemOnc

We're pleased to bring you our latest podcast! Join leading experts as they discuss the impact of artificial intelligence and machine learning in the treatment of MDS:

🎧: http://ow.ly/1Akr50J8EBm

#MDSsm #MyelodysplasticSyndromes

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter